{"entity":{"type":"insider","cik":"0001688195","url":"/insider/0001688195","json_url":"/insider/0001688195.json","name":"Farzaneh-Far Ramin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2019-06-19","last":"2020-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Farzaneh-Far Ramin","source":"filing","n_filings":10,"first_seen":"2019-06-19","last_seen":"2020-03-18"}],"transactions":[{"id":2212830,"accession":"0001104659-20-035491","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-035491","line_url":"/filing/0001104659-20-035491#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":45.1648,"price_display":"45.16","price_state":"stated","total_value":478521.056,"total_display":"478,521.06","total_whole":"478,521","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2212538,"accession":"0001104659-20-023526","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-023526","line_url":"/filing/0001104659-20-023526#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":46.6116,"price_display":"46.61","price_state":"stated","total_value":493849.902,"total_display":"493,849.90","total_whole":"493,850","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":2297208,"accession":"0001104659-20-004828","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-004828","line_url":"/filing/0001104659-20-004828#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":46.9505,"price_display":"46.95","price_state":"stated","total_value":497440.5475,"total_display":"497,440.55","total_whole":"497,441","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-16","scope":"insider"},{"id":8030607,"accession":"0001104659-19-073910","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-073910","line_url":"/filing/0001104659-19-073910#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":47.2252,"price_display":"47.23","price_state":"stated","total_value":500350.994,"total_display":"500,350.99","total_whole":"500,351","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider"},{"id":7912984,"accession":"0001104659-19-065130","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-065130","line_url":"/filing/0001104659-19-065130#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":46.6559,"price_display":"46.66","price_state":"stated","total_value":494319.2605,"total_display":"494,319.26","total_whole":"494,319","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-18","scope":"insider"},{"id":8201225,"accession":"0001104659-19-054727","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-054727","line_url":"/filing/0001104659-19-054727#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":46.8871,"price_display":"46.89","price_state":"stated","total_value":496768.8245,"total_display":"496,768.82","total_whole":"496,769","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-17","scope":"insider"},{"id":7777535,"accession":"0001104659-19-050300","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-050300","line_url":"/filing/0001104659-19-050300#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":25.2643,"price_display":"25.26","price_state":"stated","total_value":267675.2585,"total_display":"267,675.26","total_whole":"267,675","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-16","scope":"insider"},{"id":8237667,"accession":"0001104659-19-047564","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-047564","line_url":"/filing/0001104659-19-047564#line-3","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":27.7703,"price_display":"27.77","price_state":"stated","total_value":294226.3285,"total_display":"294,226.33","total_whole":"294,226","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-27","scope":"insider"},{"id":7860716,"accession":"0001104659-19-040610","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-040610","line_url":"/filing/0001104659-19-040610","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":33.09553968853233,"price_display":"33.10","price_state":"stated","total_value":350647.243,"total_display":"350,647.24","total_whole":"350,647","shares_owned_after":11348.0,"shares_owned_after_display":"11,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-16","scope":"insider","n_lines":2},{"id":8310227,"accession":"0001104659-19-036491","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-036491","line_url":"/filing/0001104659-19-036491","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688195","owner_name":"Farzaneh-Far Ramin","owner_display_name":"Farzaneh-Far Ramin","owner_url":"/insider/0001688195","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10595.0,"shares_display":"10,595","price_per_share":21.838982444549316,"price_display":"21.84","price_state":"stated","total_value":231384.019,"total_display":"231,384.02","total_whole":"231,384","shares_owned_after":7132.0,"shares_owned_after_display":"7,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Officer (Chief Medical Officer)","n_filings":10,"first_seen":"2019-06-19","last_seen":"2020-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688195","retrieved_at":"2026-08-26T11:57:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}